🇺🇸 FDA
Patent

US 11834436

Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

granted A61PA61P1/16A61P13/12

Quick answer

US patent 11834436 (Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof) held by Enanta Pharmaceuticals, Inc. expires Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Enanta Pharmaceuticals, Inc.
Grant date
Tue Dec 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P1/16, A61P13/12, A61P25/28, A61P29/00